单吻合术十二指肠回肠旁路术套筒胃切除术（SADI-S）与套筒胃切除术和Roux-en-Y胃旁路术的比较结果：使用MBSAQIP数据注册的倾向匹配分析。

IF 3.2 3区医学 Q1 SURGERY

Surgery for Obesity and Related Diseases Pub Date : 2026-11-01 Epub Date: 2026-06-15 DOI:10.1016/j.soard.2026.06.008

Mouhammad Halabi M.D., Sahaana Sridhar D.O., Warda Alam M.D., Oliver A. Varban M.D., Jeffery Genaw M.D., Arthur M. Carlin M.D., Hassan Nasser M.D.

{"title":"单吻合术十二指肠回肠旁路术套筒胃切除术（SADI-S）与套筒胃切除术和Roux-en-Y胃旁路术的比较结果：使用MBSAQIP数据注册的倾向匹配分析。","authors":"Mouhammad Halabi M.D., Sahaana Sridhar D.O., Warda Alam M.D., Oliver A. Varban M.D., Jeffery Genaw M.D., Arthur M. Carlin M.D., Hassan Nasser M.D.","doi":"10.1016/j.soard.2026.06.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) is a procedure that is being performed more commonly. Despite its growing adoption, limited data exist comparing its short-term safety to established bariatric operations.</div></div><div><h3>Objectives</h3><div>To compare 30-day postoperative outcomes of SADI-S with those of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) using a national clinical registry.</div></div><div><h3>Setting</h3><div>Analysis of data from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), encompassing accredited bariatric centers across the United States and Canada.</div></div><div><h3>Methods</h3><div>The MBSAQIP database was queried for adult patients (≥18 years) undergoing primary laparoscopic SADI-S, SG, or RYGB between 2021 and 2023. Propensity score matching (1:1) was performed to adjust for 19 preoperative demographic and comorbidity variables, yielding matched cohorts for SADI-S versus SG (n = 4017 each) and SADI-S versus RYGB (n = 4017 each). Thirty-day postoperative outcomes were compared between matched groups.</div></div><div><h3>Results</h3><div>Compared with SG, SADI-S was associated with a higher overall complication rate (3.7% vs 2.4%, <em>P</em> < .01) including higher rates of pneumonia, bowel obstruction, emergency department visits, reintervention, readmission, and reoperation. In contrast, overall complication rates were similar between SADI-S and RYGB (3.7% vs 4.3%, <em>P</em> = .14). SADI-S demonstrated higher pulmonary embolism rates, whereas RYGB had more reinterventions and emergency department visits.</div></div><div><h3>Conclusions</h3><div>SADI-S is associated with higher 30-day morbidity compared to SG but demonstrates short-term safety comparable to RYGB. These findings support SADI-S as a safe bariatric surgery option when performed in appropriately selected patients at accredited centers.</div></div>","PeriodicalId":49462,"journal":{"name":"Surgery for Obesity and Related Diseases","volume":"22 11","pages":"Pages 1250-1256"},"PeriodicalIF":3.2000,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative outcomes of single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) versus sleeve gastrectomy and Roux-en-Y gastric bypass: a propensity-matched analysis using the MBSAQIP data registry\",\"authors\":\"Mouhammad Halabi M.D., Sahaana Sridhar D.O., Warda Alam M.D., Oliver A. Varban M.D., Jeffery Genaw M.D., Arthur M. Carlin M.D., Hassan Nasser M.D.\",\"doi\":\"10.1016/j.soard.2026.06.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) is a procedure that is being performed more commonly. Despite its growing adoption, limited data exist comparing its short-term safety to established bariatric operations.</div></div><div><h3>Objectives</h3><div>To compare 30-day postoperative outcomes of SADI-S with those of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) using a national clinical registry.</div></div><div><h3>Setting</h3><div>Analysis of data from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), encompassing accredited bariatric centers across the United States and Canada.</div></div><div><h3>Methods</h3><div>The MBSAQIP database was queried for adult patients (≥18 years) undergoing primary laparoscopic SADI-S, SG, or RYGB between 2021 and 2023. Propensity score matching (1:1) was performed to adjust for 19 preoperative demographic and comorbidity variables, yielding matched cohorts for SADI-S versus SG (n = 4017 each) and SADI-S versus RYGB (n = 4017 each). Thirty-day postoperative outcomes were compared between matched groups.</div></div><div><h3>Results</h3><div>Compared with SG, SADI-S was associated with a higher overall complication rate (3.7% vs 2.4%, <em>P</em> < .01) including higher rates of pneumonia, bowel obstruction, emergency department visits, reintervention, readmission, and reoperation. In contrast, overall complication rates were similar between SADI-S and RYGB (3.7% vs 4.3%, <em>P</em> = .14). SADI-S demonstrated higher pulmonary embolism rates, whereas RYGB had more reinterventions and emergency department visits.</div></div><div><h3>Conclusions</h3><div>SADI-S is associated with higher 30-day morbidity compared to SG but demonstrates short-term safety comparable to RYGB. These findings support SADI-S as a safe bariatric surgery option when performed in appropriately selected patients at accredited centers.</div></div>\",\"PeriodicalId\":49462,\"journal\":{\"name\":\"Surgery for Obesity and Related Diseases\",\"volume\":\"22 11\",\"pages\":\"Pages 1250-1256\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2026-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgery for Obesity and Related Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1550728926007458\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/6/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgery for Obesity and Related Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1550728926007458","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/15 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

摘要

背景：单吻合术十二指肠回肠旁路与套筒胃切除术（SADI-S）是一种较为常见的手术。尽管越来越多的人采用这种方法，但将其短期安全性与已建立的减肥手术进行比较的数据有限。目的：通过国家临床登记比较sdi - s与袖胃切除术（SG）和Roux-en-Y胃旁路术（RYGB）术后30天的结果。环境：分析来自代谢和减肥手术认证和质量改进计划（MBSAQIP）的数据，包括美国和加拿大认可的减肥中心。方法：在MBSAQIP数据库中查询2021年至2023年间接受原发性腹腔镜SADI-S、SG或RYGB手术的成人患者（≥18岁）。进行倾向评分匹配（1:1）以调整19个术前人口学和合并症变量，得到SADI-S与SG（各n = 4017）和SADI-S与RYGB（各n = 4017）的匹配队列。比较两组术后30天的结果。结果：与SG相比，SADI-S的总并发症发生率更高（3.7% vs 2.4%, P < 0.01），包括肺炎、肠梗阻、急诊就诊、再干预、再入院和再手术的发生率更高。相比之下，SADI-S和RYGB的总并发症发生率相似（3.7% vs 4.3%, P = .14）。SADI-S表现出更高的肺栓塞率，而RYGB则有更多的再干预和急诊就诊。结论：与SG相比，SADI-S的30天发病率更高，但其短期安全性与RYGB相当。这些发现支持SADI-S作为一种安全的减肥手术选择，如果在认可的中心对适当选择的患者进行手术。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Comparative outcomes of single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) versus sleeve gastrectomy and Roux-en-Y gastric bypass: a propensity-matched analysis using the MBSAQIP data registry

Background

Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) is a procedure that is being performed more commonly. Despite its growing adoption, limited data exist comparing its short-term safety to established bariatric operations.

Objectives

To compare 30-day postoperative outcomes of SADI-S with those of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) using a national clinical registry.

Setting

Analysis of data from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), encompassing accredited bariatric centers across the United States and Canada.

Methods

The MBSAQIP database was queried for adult patients (≥18 years) undergoing primary laparoscopic SADI-S, SG, or RYGB between 2021 and 2023. Propensity score matching (1:1) was performed to adjust for 19 preoperative demographic and comorbidity variables, yielding matched cohorts for SADI-S versus SG (n = 4017 each) and SADI-S versus RYGB (n = 4017 each). Thirty-day postoperative outcomes were compared between matched groups.

Results

Compared with SG, SADI-S was associated with a higher overall complication rate (3.7% vs 2.4%, P < .01) including higher rates of pneumonia, bowel obstruction, emergency department visits, reintervention, readmission, and reoperation. In contrast, overall complication rates were similar between SADI-S and RYGB (3.7% vs 4.3%, P = .14). SADI-S demonstrated higher pulmonary embolism rates, whereas RYGB had more reinterventions and emergency department visits.

Conclusions

SADI-S is associated with higher 30-day morbidity compared to SG but demonstrates short-term safety comparable to RYGB. These findings support SADI-S as a safe bariatric surgery option when performed in appropriately selected patients at accredited centers.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Surgery for Obesity and Related Diseases 医学-外科

CiteScore

6.70

自引率

12.90%

发文量

570

审稿时长

56 days

期刊介绍： Surgery for Obesity and Related Diseases (SOARD), The Official Journal of the American Society for Metabolic and Bariatric Surgery (ASMBS) and the Brazilian Society for Bariatric Surgery, is an international journal devoted to the publication of peer-reviewed manuscripts of the highest quality with objective data regarding techniques for the treatment of severe obesity. Articles document the effects of surgically induced weight loss on obesity physiological, psychiatric and social co-morbidities.